文献速递咽喉与嗓音

碱性成纤维细胞生长因子注射治疗声带萎缩的疗效

Therapeutic Efficacy of Basic Fibroblast Growth Factor in Patients With Vocal Fold Atrophy.
PubMed 文献 · Laryngoscope · 2020-02-08

注射后VHI、MPT、jitter、shimmer及音域均改善并持续6个月;70岁以上患者VHI和MPT在3、6个月亦改善,且改善程度与70岁以下者无显著差异。结论认为单次bFGF注射对早期和晚期老年声带萎缩患者安全有效。

要点

  • 单次bFGF声带注射可改善年龄相关声带萎缩患者的VHI、MPT及声学指标,效果持续6个月。
  • 70岁以上患者注射后VHI和MPT在3、6个月均改善,改善程度与70岁以下者无显著差异。
  • bFGF注射对早期和晚期老年声带萎缩患者均安全有效。

核心结论

  • 单次bFGF注射治疗对早期和晚期老年声带萎缩患者均安全有效,嗓音结局改善可持续6个月。

主要发现

  • 注射后VHI、MPT、jitter、shimmer和音域均改善,且效果持续6个月。
  • 70岁以上患者注射后3个月和6个月VHI和MPT均改善。
  • 70岁以上与70岁以下患者VHI和MPT改善程度无显著差异。

关键数值与推荐

  • 嗓音结局在注射后3个月和6个月通过声学及空气动力学测量评估。
  • 证据等级为2c。

临床怎么用

  • 对于年龄相关声带萎缩患者,可考虑单次bFGF声带注射以改善嗓音相关生活质量和发声功能。
  • 对70岁以上老年患者,bFGF注射同样可考虑,其嗓音改善程度与较年轻患者相当。

局限性

  • 本研究为回顾性病历回顾,非随机对照设计。
  • 原文未报告样本量以外的具体统计值及长期随访结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: In recent years, basic fibroblast growth factor (bFGF) injection has been used in the treatment of aging-related vocal fold atrophy. This injection not only improves closure by increasing the mass of the vocal fold but also improves its viscoelasticity. However, it has been reported that fibroblasts targeted by bFGF treatment decrease in number with age. The purpose of this study was to examine the effects of local injection of bFGF on age-related vocal atrophy as well as the influence of age on phonological outcomes. STUDY DESIGN: Retrospective chart review. METHODS: Fifty-three patients with age-related vocal fold atrophy underwent single injections of bFGF in their vocal folds. Phonological outcomes were evaluated 3 and 6 months after injection by acoustic and aerodynamic measurements. RESULTS: Voice Handicap Index (VHI), maximum phonation time (MPT), jitter, shimmer, and pitch range improved after injection, and the effects continued for 6 months. In those over 70 years of age, VHI and MPT showed improvement at 3 and 6 months after injection. In addition, the degree of improvement in VHI and MPT did not differ significantly between those older than 70 years and those younger than 70 years. CONCLUSIONS: Regenerative treatments dependent on bFGF single injection was safe and effective for both early and late elderly patients suffering of vocal fold atrophy. LEVEL OF EVIDENCE: 2c Laryngoscope, 2020.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Okui A, Konomi U, Kanazawa T, et al. Therapeutic Efficacy of Basic Fibroblast Growth Factor in Patients With Vocal Fold Atrophy. Laryngoscope. 2020. PMID: 32034961. doi:10.1002/lary.28541

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。